Order Article Reprints

Abdallah HM, El-Halawany AM, Sirwi A, El-Araby AM, Mohamed GA, Ibrahim SRM, Koshak AE, Asfour HZ, Awan ZA, A. Elfaky M. Repurposing of Some Natural Product Isolates as SARS-COV-2 Main Protease Inhibitors via In Vitro Cell Free and Cell-Based Antiviral Assessments and Molecular Modeling Approaches. Pharmaceuticals. 2021; 14(3):213. https://doi.org/10.3390/ph14030213

Abdallah, Hossam M., Ali M. El-Halawany, Alaa Sirwi, Amr M. El-Araby, Gamal A. Mohamed, Sabrin R. M. Ibrahim, Abdulrahman E. Koshak, Hani Z. Asfour, Zuhier A. Awan, and Mahmoud A. Elfaky. 2021. "Repurposing of Some Natural Product Isolates as SARS-COV-2 Main Protease Inhibitors via In Vitro Cell Free and Cell-Based Antiviral Assessments and Molecular Modeling Approaches" Pharmaceuticals 14, no. 3: 213. https://doi.org/10.3390/ph14030213

Abdallah, H. M., El-Halawany, A. M., Sirwi, A., El-Araby, A. M., Mohamed, G. A., Ibrahim, S. R. M., Koshak, A. E., Asfour, H. Z., Awan, Z. A., & A. Elfaky, M. (2021). Repurposing of Some Natural Product Isolates as SARS-COV-2 Main Protease Inhibitors via In Vitro Cell Free and Cell-Based Antiviral Assessments and Molecular Modeling Approaches. Pharmaceuticals, 14(3), 213. https://doi.org/10.3390/ph14030213